Home
University of Bergen

Centre for Cancer Biomarkers CCBIO

Main content

Collage of photos from CCBIO situations; research, teaching, symposia.

Centre for Cancer Biomarkers (CCBIO) is a Centre of Excellence at the Faculty of Medicine, University of Bergen. 

The center is working on new cancer biomarkers and targeted therapy, and has particular focus on mechanisms that show how cancer cells are affected by the microenvironment in the tumors, and what significance this has for cancer proliferation and poor prognosis. See the 1 minute video CCBIO in a Nutshell. Centre Director is Lars A. Akslen, Department of Clinical Medicine. Read about our research and activities in the CCBIO Annual Report.

Project managers
CCBIO's principal investigators:

News
Portrait of Lars A. Akslen next to the Helse Vest Research Award diploma.

Prestigious recognitions to Lars A. Akslen and CCBIO

The regional health authority Helse Vest’s Research Award 2023 goes to Professor Lars Andreas Akslen and CCBIO for ground-breaking research on cancer biomarkers. Akslen has also been subject to another prestigious recognition this fall, as he was recently elected as member of the Academia Europaea.

News
Christiane on stage, with a petridish in her hand.

Brilliant performance at Forsker Grand Prix

Forsker Grand Prix took place in Bergen September 27, where nine young researchers were competing for Best Presenter, getting only four minutes to convey their research in front of an audience and three judges. Among the nine was CCBIO's and the Department of Clinical Science's PhD Candidate...

News
Group photo from the CCBIO Symposium in 2023.

Fertilizing cancer research collaborations at the 11th CCBIO Annual Symposium 2023

The 11th CCBIO Annual Symposium was this time enlarged with a generous time frame and two overnight stays, May 8-11, 2023. Although there was an option for online attendance, only 14 participants chose to attend online, and the rest of the total of 235 chose to enjoy the company of colleagues and...

International exchange
Amalie, Ole and Camilla sitting in a restaurant, posing for the camera.

Bringing home new perspectives

This winter/spring, three of CCBIO's students got the opportunity to have research stays at different labs of the Vascular Biology Program in Boston, through CCBIO's INTPART collaboration with Harvard Medical School and Boston Children's Hospital. PhD Candidate Camilla Tvedt Ekanger, Medical Student...

International collaboration
Image though the microscope.

Collaboration with Tanzania on head and neck cancer

The research group of Professor Daniela Costea is currently engaged in a DIKU/NORPART funded collaboration project with partners in Tanzania, establishing immunohistochemistry for p16 as a method for more precise diagnostic of head and neck cancers (HNC). CCBIO has just had a visit from Tanzania,...

Shortcuts: Read CCBIO's Annual Reports and the CCBIO Newsletter

CCBIO is established in 2013 by the Research Council of Norway in collaboration with the University of Bergen. Other important sources of financial support are Helse Vest and the Norwegian Cancer Society. CCBIO is part of the Research Council of Norway's Centres of Excellence (CoE) scheme. The scheme organizes the activities of Norway’s foremost scientific circles in centres to achieve ambitious scientific objectives through collaboration and long-term basic funding.